http://www.einstien.yu.edu - Neonatologist Judy Aschner, M.D., discusses how her personal experience of giving birth to a critically ill premature baby informs her focus on family-centered care for hospitalized children. She also gives perspective on the latest research for treating preemies and the long-term negative effects associated with being born even two weeks early. Dr. Aschner is professor and Michael I. Cohen, M.D., University Chair of Pediatrics at Albert Einstein College of Medicine and Physician-in-Chief and Chair of Pediatrics at The Children's Hospital at Montefiore. This edition of Einstein On, a research and medicine podcast, is hosted by Gordon Earle, associate dean for communications and public affairs.

http://www.einstein.yu.edu - Keith Ayoob, Ed.D., R.D., discusses childhood obesity and details the real-world tools he uses to help parents of obese children better manage their child’s weight. He also explains how he helps parents who don’t recognize that their children are overweight. Dr. Ayoob is associate clinical professor of pediatrics and director of the nutrition clinic at the Children's Evaluation and Rehabilitation Center at Albert Einstein College of Medicine. This edition of Einstein On, a research and medicine podcast, is hosted by Paul Moniz, managing director of communications and marketing at Einstein.

http://www.einstein.yu.edu - Joe Verghese, M.B.B.S, M.S, discusses the complex connections between frailty, mobility and cognitive decline in older adults and research to identify, prevent and treat frailty. Dr. Verghese is Chief of Geriatrics at Albert Einstein College of Medicine and Montefiore Medical Center and a professor of neurology and of medicine at Einstein. This edition of Einstein On, a research and medicine podcast, is hosted by Paul Moniz, managing director of communications and marketing at Einstein.

http://www.einstein.yu.edu - John Foxe, Ph.D., discusses the latest trends in autism research, theories and treatment including his own findings on why children with autism integrate information from the senses differently. Dr. Foxe is director of research at Albert Einstein College of Medicine's Children's Evaluation and Rehabilitation Center and professor of pediatrics and of neuroscience. This edition of Einstein On is hosted by Gordon Earle, associate dean for communications and public affairs.

http://www.einstein.yu.edu - Harry Ostrer, M.D., discusses how genetic sequencing is changing the course of treatment for common diseases such as cancer, Alzheimer’s disease and heart disease by identifying individuals at higher risk. It can also play a role in personalizing treatment: sequencing the genome of a cancer, for example, can yield information that leads to personalized, targeted therapy. He addresses concerns that genetic information can affect employability or insurability and reviews existing safeguards. Dr. Ostrer is a professor of pathology and of genetics at Albert Einstein College of Medicine and director of genetic and genomic testing in clinical pathology at Montefiore Medical Center.

http://www.einstein.yu.edu - Tia Powell, M.D., explores issues in the emerging field of clinical bioethics including end of life care, genetic testing, protection of participants in clinical research studies and public health policy. Dr. Powell is director of the Montefiore Einstein Center for Bioethics and director of Einstein-Cardozo Bioethics Graduate Studies. This edition of Einstein On, a research and medicine podcast, is hosted by Paul Moniz, managing director of communications and marketing at Albert Einstein College of Medicine.

http://www.einstein.yu.edu - Jeffrey Pessin, Ph.D., discusses basic and clinical diabetes research being conducted at Einstein and Montefiore Medical Center, including the brain’s influence on appetite, autoimmune and stem cell therapies, and the efforts to develop an artificial pancreas. Dr. Pessin is director of Einstein’s Diabetes Research Center. This edition of Einstein On is hosted by Gordon Earle, associate dean for communications and public affairs.

http://www.einstein.yu.edu - Jeffrey Pessin, Ph.D., explains the causes and treatments for type 1 diabetes, type 2 diabetes and malnutrition diabetes, a growing problem in the developing world. He also addresses the spiking rates of type 2 diabetes in the U.S. Dr. Pessin is director of the Diabetes Research Center at Albert Einstein College of Medicine. This edition of Einstein On is hosted by Gordon Earle, associate dean for communications and public affairs.

http://www.einstein.yu.edu - Physician-researcher Joseph Sparano, M.D., discusses the difference between personalized and precision medicine and explains how both are changing the treatment and outcomes for cancer patients. He also discusses research and clinical trials taking place at Albert Einstein College of Medicine and Montefiore Medical Center. Dr. Sparano is associate director for clinical research at Albert Einstein Cancer Center and associate chairman of medical oncology at Montefiore Einstein Center for Cancer Care. This edition of Einstein On, a research and medicine podcast, is hosted by Paul Moniz, managing director of communications and marketing.

http://www.einstein.yu.edu - Richard Lipton, M.D., discusses the moral and ethical issues about testing and/or informing patients that they are likely to get Alzheimer’s disease. Dr. Lipton is the Edwin S. Lowe Chair at Albert Einstein College of Medicine of Yeshiva University, vice chair of neurology at Montefiore Medical Center and director of the Einstein Aging Study. This edition of Einstein On, a research and medicine podcast, is hosted by Gordon Earle, associate dean for communications and public affairs at Einstein.